Infinity Holdings Sidecar I and Infinity Holdings, managed by Infinity Investment Management, Investment Arm and others entered into a share purchase agreement to acquire 43.73% stake in Jagsonpal Pharmaceuticals Limited (NSEI:JAGSNPHARM) from Aresko Progressive Private Limited and Rajpal Singh Kochhar for INR 2.7 billion on February 21, 2022. As per the transaction, Infinity Investment Management will acquire 1,14,55,500 shares representing 43.73% at INR 235 per share. After the transaction, Aresko Progressive Private Limited stake will reduce from 65.71% to 21.99% in Jagsonpal Pharmaceuticals Limited. Jefferies LLC acted as financial advisor to Jagsonpal Pharmaceuticals Limited. Aditya Patni, Sudhir Bassi, Abhishek Dadoo, Shailendra Bhandare, Abhinav Rastogi, Jeevan Ballav Panda and Avnish Sharma of Khaitan & Co. acted as legal advisor to Jagsonpal Pharmaceuticals Limited.

Infinity Holdings Sidecar I and Infinity Holdings, managed by Infinity Investment Management, Investment Arm and others completed the acquisition of 43.73% stake in Jagsonpal Pharmaceuticals Limited (NSEI:JAGSNPHARM) from Aresko Progressive Private Limited and Rajpal Singh Kochhar for INR 2.7 billion In FY 23.